About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Report Type
Organization
Disposition
Year
Month
Found 72611 record(s)
Req # A-2024-000366
All emails and associated attachments corresponding to the leadup, request for, and ultimately deemed-unnecessary Issue Analysis Summary (IAS) that is referred to in the Inquiry of Ministry question number Q-2670 (2 May 2024) by Member of Parliament…Organization: Health Canada
September 2024
Req # A-2024-000436
Documents on the smoking prevalence of equity groups in Canada for calendar years 2018-2023.Organization: Health Canada
September 2024
Req # A-2024-000450
Whether the drug Fasudil has ever been requested as part of the Special Access Program (SAP) for use in Canada. For which indications.Organization: Health Canada
September 2024
Req # A-2024-000560
Between December 1, 2021 and Dec 31, 2022, provide those communications Health Canada (HC), the National Advisory Committee on Immunization (NACI), and the communications branch of the Ministry of Health sent to the media including CBC, Toronto Star…Organization: Health Canada
September 2024
Req # A-2024-000583
All documents, regarding The Minister of Diversity, Inclusion and Persons with Disabilities and The Minister of Mental Health and Addictions event on August 16, 2024; the scheduling and then subsequent cancellation of the planned media availability.Organization: Health Canada
September 2024
Req # A-2024-000584
The Exemptions Division Office of Controlled Substances / Controlled Substances and Cannabis Branch Health Canada / Government of Canada The Exemptions Division grants Section 56 exemptions for various religious organizations to serve ayahuasca/…Organization: Health Canada
September 2024
Req # A-2024-000591
For all employees who work onsite where there exists a nuclear reactor, provide all electronic and hardcopy records of leave as a result of cancer, and/or termination. Provide all studies conducted by the department that discuss employee deaths as…Organization: Health Canada
September 2024
Req # A-2024-000639
All communications leading up to and regarding Health Canada's decision to order the destruction of covid vaccines in Canada. CTV News, 4 Sep 2024: "Health Canada orders provinces to destroy old COVID-19 vaccines amid wait for new batch…Organization: Health Canada
September 2024
Req # A-2024-000647
With respect to generic drug in Health Canada’s list of “Generic Drug Submissions Under Review” dated 2022-06-22 for the medicinal ingredient mesalazine, if the applicant has made a request for reconsideration of Health Canada’s decision, a copy of…Organization: Health Canada
September 2024
Req # A-2024-000721
Please provide review reports and records of discussion of biowaiver requirements and bioequivalence for Cytex Pharmaceuticals Inc.’s “PROGESTERONE INJ” (Drug Identification Number (DIN) 01977652). The product was first marketed in December 1992.Organization: Health Canada
September 2024